期刊文献+

杂质化合物的可专利性问题判断及分析

Judgement and analysis of patentability of impurity compounds
原文传递
导出
摘要 在化学及生物医药领域的专利布局中,杂质化合物是近年来较为突出的一个热点问题,其可专利性也具有颇多争议。本文笔者对不同情况下研发得到的杂质化合物的可专利性的核心要求,即实用性、专利保护的客体、新颖性和创造性方面的问题进行了全面的判断和分析,希望给相关领域从事研发、生产、质量、知识产权方面的人士提供一些有益参考。 In the patent layout in the field of chemistry and biopharmaceutical industry,impurity compounds have become a hot topic in recent years,and their patentability has also been quite controversial. In this paper,the authors made comprehensive judgments and analysis of the key requirements of the patentability of impurity compounds developed under different circumstances,including requirements of utility,subject matter of patent,novelty and inventiveness. We hope to provide some useful references for people in the fields of R&D,production,quality control and intellectual property.
作者 王卫彬 薛琦 黄璐 WANG Wei-bin;XUE Qi;HUANG Lu(Shanghai Beshining Law Office,Shanghai 200032,China;Guangzhou Wellhealth Bio-pharma Co.,Ltd.,Guangzhou 510200,China;Wuhan University School of Pharmaceutical Sciences,Wuhan 430072,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2019年第4期395-399,共5页 Chinese Journal of New Drugs
关键词 杂质 可专利性 科学发现 新颖性 创造性 impurity compounds patentability science discovery novelty inventiveness
  • 相关文献

参考文献3

二级参考文献32

  • 1马维野.切实抓好源头 促进目的实现[J].中国发明与专利,2008(12):8-9. 被引量:3
  • 2冒莉,郑启泰,吕扬.固体药物多晶型的研究进展[J].天然产物研究与开发,2005,17(3):371-375. 被引量:48
  • 3杨莉,李野.关于中药专利保护特殊规则的探讨[J].中国药房,2006,17(10):728-730. 被引量:10
  • 4中华人民共和国国家知识产权局.专利审查指南[M].北京:知识产权出版社.2010.
  • 5GOODSON SH. Challenges and strategies for patenting new solid forms[ EB/OL]. 2015 [2015 - 07 - 30 ]. http ://www. fr. com/ files/uploads/newsolidforms2, pdf.
  • 6JASCO. Raman Spectroscopy Analysis of Crystalline Polymorphs for Pharmaceutical Development [ EB/OL]. 2015 [ 2015 - 07 - 30 ]. http ://www. jascoinc, com/pharmaceutical/raman-spectros- copy-analysis-of-crystalline-polymorphs-for-pharmaceutical-devel- opment.
  • 7国家药典委员会.0451X射线衍射法[EB/OL].2015[2015-07-30].http://www.chp.org.cn/export/sites/chp/resource/2014b/2014073009473072463.pdf.
  • 8深圳万乐药业有限公司.醋酸阿比特龙的多晶型物及其制备方法:中国,200910189173.1[P].2014-03-26.
  • 9HAN J. Advances in Characterization of Pharmaceutical Hydrates [ EB/OL]. 2006 [ 2015 - 07 - 30] http ://tbiweb. org/tbi/file_ dir/TB/2006/TBI2006 _3 _25. pdf.
  • 10RANDALL CS, ROCCO WL, RICOU P. XRD in Pharmaceutical analysis: a versatile tool for problem-solving [ EB/OL ]. 2010 [ 2015 - 07 - 30]. http ://www. americanpharmaceuticalreview. com/Featured-Articles/115052-XRD-in-Pharmaeeutieal-Analysis- A -Versatile-Tool-for-Problem -Solving.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部